TAMs can be recruited into the tumor microenvironment after the colonization of tumor cells in metastatic organs to form an immune microenvironment and act as mediators of cancer-associated inflammation through the release of transcription factors (NF-κB, STAT3) that promote tumor growth. The gene discussed is NFKB1; the disease is cancer.